Ischemic heart Disease Market Size, Share | Industry Analysis Report 2022

Ischemic heart Disease Market report is an expert analysis report which gives detail information about industry players, segmentation and regional data in-depth.

The Middle East and Africa Ischemic heart disease market are showing the steady growth; mainly owing to increase in consumption of smoking, diabetes mellitus and cholesterol levels. There are few more factors which lead the occurrence of Ischemic heart disease, such as Hypertension, Genetic and hereditary factors, sedentary lifestyle, and Stress.

According to, Dubai Health Authority, Heart disease causes three in every 10 deaths in the UAE. Also, according to the Centers for Disease Control and Prevention (CDC), around 17.7 million people died with CVD, which hold 31% of all global deaths. Whereas in Saudi Arabia its holds 6% of total death. Companies are continually inventing new treatment to capture the Middle East and Africa market. 

The market is growing at the CAGR of 3.1% and expected to reach to US$ 2.84 billion by 2022

Ischemic heart Disease Market Segmentation:

Middle-East and Africa Ischemic heart Disease market has been segmented on the basis of type which comprise stable angina, unstable angina, myocardial infarction, and Others.  On the basis of diagnosis the market is segmented into (Electrocardiogram, Echocardiography, Stress Testing, Coronary angiography, Magnetic resonance imaging (MRI), Chest X Ray, and Others. On the basis of treatment type market is segmented into Medications, Surgery, Lifestyle changes, and others.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2585

Ischemic heart Disease Market Key Players

Some of the key players in this market are: King Faisal Specialist Hospital and Research Centre (Saudi Arabia), Riyadh Military Hospital (Saudi Arabia), Hamad Medical Corporation (Qatar), American Hospital Dubai, Ganzouri Specialized Hospital (Egypt), AstraZeneca (U.K.), Sanofi (France), Merck Sharp & Dohme Corp.(U.S.), AUM Cardiovascular (US), HeartWare (U.S.).

Ischemic heart Disease Market Regional Analysis

According to the World Health Organization (WHO), in 2015, over 1.1 billion people were smoking tobacco, and male population consumes more in comparison to female. Although it is declining worldwide, but in many countries, the prevalence of tobacco smoking appears to be increasing, especially in the WHO Eastern Mediterranean Region and the African Region. The most affected countries in the Middle East are Egypt, Iran, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia (SAU), United Arab Emirates (UAE) and Yemen and in Africa Algeria, and Tunisia. World organization is more focused in order to provide funds to the countries of this region in order to improve the quality of life.

UAE is the largest market for ischemic heart disease in the entire Middle East and Africa market owing to the presence of huge population suffering with disease related to heart. The rest of Africa market is, however the fastest growing with a huge unmet medical need and high rate of tobacco and alcohol consumption which leads the incidence of many diseases. Moreover, the government of these countries are looking support from developed and developing nation in order to get effective and advanced treatment at lower cost.

Companies are also looking forward to this market owing to the huge gap between demand and supply of the patients. According to the report published by the Centers for Disease Control and Prevention (CDC), in 2015, CDC has worked with the Kingdom of Saudi Arabia from 20 years, along with the Ministry of Health, WHO, local partners, and other U.S. 

Table Of Content

1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

        TOC Continued….!

Browse Complete Report Details @

https://www.marketresearchfuture.com/reports/mea-ischemic-heart-disease-market-2585

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: [phone]

Email: [email protected]